'poc' 검색 결과

Configure repository-local tracker, triage, and domain-document conventions needed by the Matt Pocock engineering skills.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

为本仓库配置工程技能——设置其 issue tracker、分诊标签词汇表和领域文档布局。首次使用其他工程技能前运行一次。

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when user asks about 藏传, 格鲁派, Gelug, 黄教, 三主要道, 菩提道次第广论, lam rim, 密宗道次第广论, 应成中观, 缘起性空, 辨了不了义, 宗喀巴, Tsongkhapa, Je Rinpoche, 甘丹寺, 戒律, 因明, 月称, 入中论, or wants teaching in 宗喀巴大师 Tsongkhapa's voice. Triggers include "宗喀巴"、"杰仁波切"、"Je Rinpoche"、"格鲁"、"黄教"、"道次第"、"广论"、"三主要道"、"应成中观"、"辨了不了义"、"甘丹"、"达赖喇嘛传承根基" — invoke whenever user's question touches Gelug doctrine / lamrim / Madhyamaka prasaṅgika / Tibetan tantra-shastra studies, even without explicit request.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Deploy funnelcake (api + relay) to ANY environment (production, staging, poc) on GKE via ArgoCD. Use when: (1) Deploying new funnelcake commits, (2) Building Docker images for GKE (amd64), (3) Running ClickHouse migrations, (4) Troubleshooting ImagePullBackOff errors, (5) Syncing staging/poc after production deployment. Covers complete workflow with PRE-FLIGHT CHECKLIST to prevent common deployment failures.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

B2B 大客户销售 (B2B 大客户销售 / 企业级复杂销售 (Enterprise B2B Sales / Complex Selling) — 面向企业客户的高价值、长周期、多干系人复杂销售的职业认知操作系统，从业者(AE/客户经理/SE 售前/销售负责人 VP Sales/CRO)、想入行者、以及服务这行(销售咨询/enablement/RevOps)的视角。覆盖: (a) 第一性张力 — 三大方法论流派之争: **买方主导的诊断式提问 (consultative/discovery-led: SPIN 提问 → 痛点 → 方案, 「像医生先诊断再开方」) ⇄ 卖方主导的教学式挑战 (Challenger: Teach-Tailor-Take control, 用商业洞见 reframe 客户认知, 「像老师挑战客户的既有想法」) ⇄ 资格审查纪律 (MEDDIC/MEDDPICC: 先严格 qualify/disqualify, 「no deal 好过 bad deal」)**; 三派不是非此即彼, 资深人混用, 但底层世界观分歧真实(问 vs 教 vs 筛); 更深层张力 — 「过程/方法论纪律 (process rigor: 预测准确、deal inspection、qualify) ⇄ 关系/信任 (relationship: champion 培养、高管关系、人情)」, 「卖结果/业务价值 (business outcome/ROI、卖给经济决策人) ⇄ 卖产品/功能 (feature selling)」, 「多线程触达买方委员会 (multithreading buying committee) ⇄ 单一 champion 依赖」; (b) 方法论正典 (最标准化、最易蒸出高质量+CLI 化) — MEDDIC/MEDDPICC (Metrics 量化指标/Economic buyer 经济决策人/Decision Criteria 决策标准/Decision Process 决策流程/Identify Pain 痛点/Champion 内部拥护者 + Paper process 签约流程/Competition 竞争), SPIN (Situation/Problem/Implication/Need-payoff 提问序列), Challenger (商业洞见 commercial insight + reframe + 建设性张力 constructive tension + Mobilizer 调动者), Solution Selling (痛点链 pain chain/愿景创建/buying vision), Sandler (前置合约 up-front contract/痛苦漏斗 pain funnel/潜艇七步), Command of the Message (Force Management: 业务价值框架/before-after/decision criteria), Gap Selling (Keenan: 现状 current state → 期望 future state → 差距 the gap/问题中心), Miller Heiman Strategic Selling (蓝表 blue sheet/buying influences: 经济/用户/技术买家 + coach), Value Selling, BANT (老式资格框架, 多被 MEDDIC 取代); (c) 行业结构与角色 — SDR/BDR (开发/约见) → AE/客户经理 (成交) → SE/售前/Solutions Engineer (技术验证/POC/demo) → CSM (客户成功/续约扩张) → Sales Manager/VP Sales/CRO; RevOps (收入运营), Sales Enablement (赋能); land and expand (先落地再扩张)、量化指标 quota/OTE(目标总收入)/配额达成率/pipeline coverage(管道覆盖率 ~3x 业内经验法则)/win rate(赢率)/sales velocity(销售速度)/ramp time(爬坡期)/ACV·ARR·NRR(年合同额/年经常性收入/净收入留存); (d) 销售周期 (the deal/opportunity lifecycle) — prospecting 开发 → discovery 需求挖掘 → qualification 资格审查(MEDDIC) → demo/technical validation/POC 技术验证 → business case/value 业务价值与 ROI → proposal 提案 → negotiation 谈判(procurement 采购/法务/security review) → close 成交 → onboarding/expansion 交付与扩张; 干系人: champion 拥护者 vs coach 线人 vs economic buyer 经济决策人 vs blocker 阻碍者; mutual action plan/close plan(双向行动计划/成交计划); (e) 产出物与节奏 — discovery call(需求电话)、demo、business case、proposal/SOW、MAP(mutual action plan)、forecast(预测: commit/best case/pipeline 类别)、pipeline review/deal review/QBR(季度业务回顾)/account plan(客户计划); (f) 职业/招聘/薪酬 — quota/OTE/comp plan(底薪+提成)/accelerator(加速器)/SPIFF/clawback、ramp、President's Club(顶尖销售俱乐部)、SDR→AE→管理 晋升路径、rep turnover(销售流失率高); (g) 争议/批判 — Challenger 是否过誉(CEB 原始数据被质疑、insight selling 批评)、MEDDIC 沦为填表剧场(box-checking theater, 填字段不真 qualify)、活动指标 vs 质量(spray-and-pray 群发/冷电话存废之争)、AI SDR/自动化淹没收件箱(2024-2025 AI BDR 泡沫 + 邮件送达率崩溃 backlash)、SDR 军团模式是否将死(Winning by Design/signal-based GTM 取代)、配额虚高与销售 burnout、季末打折促单、销售方法论的「宗教化」与培训-认证产业链、最大竞争对手其实是「no decision/维持现状」而非对手; (h) 流派/思想谱系 — 提问诊断派(Rackham SPIN/Bosworth&Eades Solution Selling/Keenan Gap Selling) vs 挑战教学派(Dixon&Adamson Challenger/Force Management Command of the Message) vs 资格纪律派(MEDDIC: Napoli&Dunkel 起源/John McMahon/MEDDICC Andy Whyte) vs 关系战略派(Miller Heiman Strategic/Large Account) vs SaaS 现代收入架构派(Aaron Ross Predictable Revenue/Mark Roberge Sales Acceleration Formula/Jacco van der Kooij Winning by Design bowtie/David Skok 指标) vs 开发-心态派(Jeb Blount Fanatical Prospecting/Sales EQ、Anthony Iannarino、Josh Braun) vs 谈判(Chris Voss Never Split the Difference 战术同理心)。不含: B2C/零售/电商导购销售、纯电话客服/客户支持、纯渠道/分销管理(channel 虽相关但聚焦直销复杂销售)、纯 marketing/需求生成(demand gen 虽上游但本 skill 聚焦销售执行)、纯 CSM 客户成功(虽相关但聚焦 new logo + expansion 的销售动作)。) Master OS — automated mastery of B2B 大客户销售 / 企业级复杂销售 (Enterprise B2B Sales / Complex Selling) — 面向企业客户的高价值、长周期、多干系人复杂销售的职业认知操作系统，从业者(AE/客户经理/SE 售前/销售负责人 VP Sales/CRO)、想入行者、以及服务这行(销售咨询/enablement/RevOps)的视角。覆盖: (a) 第一性张力 — 三大方法论流派之争: **买方主导的诊断式提问 (consultative/discovery-led: SPIN 提问 → 痛点 → 方案, 「像医生先诊断再开方」) ⇄ 卖方主导的教学式挑战 (Challenger: Teach-Tailor-Take control, 用商业洞见 reframe 客户认知, 「像老师挑战客户的既有想法」) ⇄

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Import structured data into Neo4j — LOAD CSV, CALL IN TRANSACTIONS, neo4j-admin database import full (offline bulk), apoc.load.csv/json, apoc.periodic.iterate, driver batch writes. Covers method selection, header file format, type coercion, null handling, ON ERROR modes, CONCURRENT TRANSACTIONS, pre-import constraint setup, and post-import validation. Use when importing CSV/JSON/Parquet files, migrating relational data to graph, or bulk-loading large datasets. Does NOT handle unstructured document/PDF/vector chunking pipelines — use neo4j-document-import-skill. Does NOT handle live app write patterns (MERGE/CREATE) — use neo4j-cypher-skill. Does NOT handle neo4j-admin backup/restore/config — use neo4j-cli-tools-skill.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

确认漏洞后产出正式 SRC/0day 提交稿 DOCX 报告的收口 skill。仅在漏洞已确认、准备成稿时使用——负责查重、过分层验证门、按固定 DOCX 骨架生成报告（Heading 2 章节 + Step 式 PoC + 内嵌真实截图）、语义化命名、放对目录、处理驳回追加。不负责挖掘/验证漏洞本身。TRIGGER：用户说"写报告/出报告/成稿/提交稿/生成漏洞报告"，或漏洞已验证到位准备交付时；或 /report。EN: Turns confirmed vulnerabilities into submission-ready DOCX reports for SRC/0day platforms (verification gates, fixed layout, step-style PoC, mandatory real screenshots). Trigger on "write report" or /report.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Design proof-of-concept frameworks for AI projects. TRIGGERS - Use when user needs help with ai-poc-framework related tasks.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

しこり玉分析。価格帯別出来高からPOC・バリューエリアを算出し、信用残データと組み合わせて含み損ポジションの所在と消化状況を判定する。

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Create and manage topic-specific project workspaces for validation, investigation, PoC, comparison, or workstreams, including meeting notes in an existing project. Use for a project workspace, cost comparison workspace, or project meeting notes. Triggers on プロジェクトワークスペース, 検証フォルダ, PoC ワークスペース, トピック別作業フォルダ, プロジェクトの議事メモ. Not for ongoing customer account operations or book manuscripts.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill recommends glucocorticoid replacement and patient education for hypocortisolemic patients after surgical remission of Cushing's syndrome. Use when a postoperative Cushing's patient exhibits low cortisol (e.g., morning cortisol <5 µg/dL) or symptoms of adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill guides postoperative management after Cushing's syndrome surgery by classifying patients into hypocortisolism, hypercortisolism, or eucortisolism based on serum cortisol levels. Use when postoperative cortisol is <5 µg/dL (hypocortisolism), >20 µg/dL (hypercortisolism), or 5-20 µg/dL (eucortisolism) to direct glucocorticoid replacement, further treatment, or monitoring.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Recommends checking and managing vitamin D according to Endocrine Society guidelines to avoid hypocalcemia in patients receiving bisphosphonates or denosumab for hypercalcemia of malignancy. Use when a clinician notes risk factors for hypocalcemia (e.g., low 25‑OH vitamin D, renal insufficiency) and asks about baseline labs before antiresorptive start.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Day-to-day operation runbook for nuxt-crouton apps — boot any app/POC locally with auth working, seed and inspect the local database (including the miniflare-vs-.data split that makes seeded data "disappear"), turn on the review overlay / eruda, observe deployed staging (tail, smoke, row counts), and capture screenshots. Use when asked to "run the app", "boot velo/fanfare/a poc locally", "why can't I log in locally", "seed the database", "the seed data doesn't show up", "look at the local db", "check what's on staging", "screenshot the app", or "where do the artifacts land".

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Design proof-of-concept frameworks for AI projects. TRIGGERS - Use when user needs help with ai-poc-framework related tasks.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

본격적인 개발 전에 작은 시제품을 실행해 아이디어의 실현 가능성과 방식별 차이를 검증합니다. 실행 결과를 근거로 채택, 조정, 보류 여부를 정리합니다.

• 아이디어의 실현 가능성을 확인합니다
• 같은 조건에서 두 방식을 비교합니다
• 본격 개발 전에 예외 조건을 검증합니다

사람이 직접 해야 하는 서비스 설정과 이전 절차를 대화형 bash 스크립트로 만듭니다. 화면 조작과 비밀 정보 입력, 설정값 저장을 단계별로 안내합니다.

• 외부 서비스 설정 절차 안내
• 인증 정보를 입력하고 .env에 저장
• CI용 GitHub 비밀 정보 설정

Claude Code에서 Git 푸시와 변경 사항 폐기 등을 실행 전에 차단하는 훅을 설정합니다. 프로젝트별 또는 전체 적용을 선택하고 차단 명령 조정과 동작 확인까지 진행합니다.

• Claude Code의 Git 푸시 차단
• 변경 사항 폐기와 브랜치 삭제 방지
• 프로젝트별 또는 전체 제한 설정

계획이나 설계를 깊이 묻는 질문으로 구체화하면서 설계 결정 기록과 용어집도 작성합니다. 하나의 대화에서 검토와 문서화를 함께 진행할 때 사용합니다.

• 질문에 답하며 계획 구체화
• 대화로 설계 심층 검토
• 검토 중 설계 결정 기록